buspirone has been researched along with Liver Dysfunction in 1 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbhaiya, RH | 1 |
| Shukla, UA | 1 |
| Pfeffer, M | 1 |
| Pittman, KA | 1 |
| Shrotriya, R | 1 |
| Laroudie, C | 1 |
| Gammans, RE | 1 |
1 trial available for buspirone and Liver Dysfunction
| Article | Year |
|---|---|
Disposition kinetics of buspirone in patients with renal or hepatic impairment after administration of single and multiple doses.
Topics: Adult; Anti-Anxiety Agents; Buspirone; Female; Humans; Kidney Diseases; Liver Cirrhosis; Liver Disea | 1994 |